Letter by Kallmünzer et al Regarding Article, “Safety of Intravenous Thrombolysis Among Patients Taking Direct Oral Anticoagulants: a Systematic Review and Meta-Analysis”
Author:
Affiliation:
1. Department of Neurology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Germany (B.K., S.S.). Department of Neurology, Klinikum Bayreuth GmbH, Bayreuth, Germany.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)
Reference5 articles.
1. Safety of Intravenous Thrombolysis Among Patients Taking Direct Oral Anticoagulants
2. Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors
3. Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in germany-updated series of 120 cases [published online January 19, 2020].;Kermer P;Int J Stroke,2020
4. Idarucizumab for Dabigatran Reversal — Full Cohort Analysis
5. Drug levels and bleeding complications in atrial fibrillation patients treated with direct oral anticoagulants.;Testa S;J Thromb Haemost,2019
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Thrombolysis After Dabigatran Reversal for Acute Ischemic Stroke;Neurology;2024-10-08
2. IV Thrombolysis for Acute Ischemic Stroke with Unknown Onset in Patients on Oral Anticoagulation;Cerebrovascular Diseases;2024-08-23
3. Specific Reversal Agents for Direct Oral Anticoagulants in Acute Stroke;Clinical and Applied Thrombosis/Hemostasis;2024-01
4. Reperfusion therapy of ischaemic strokes in oral anticoagulated patients: an expanding field in clinical practice;Neurologia i Neurochirurgia Polska;2023-12-29
5. Case report: First treatment of acute ischaemic stroke in a patient on active rivaroxaban therapy using andexanet alfa and rtPA combined with early complete recovery;Frontiers in Neurology;2023-10-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3